US State Secretary, Egypt FM discuss bloodshed in Gaza, stress strategic partnership    Egypt's Al-Sisi in Paris for Sudan Transition Conference    Sundance Institute names 20 fellows across upcoming summer labs    Grand Egyptian Museum opening to be as impressive as Royal Mummies Parade: El-Anani    Egypt to soon complete COVID-19 vaccination of tourism workers in Red Sea, South Sinai    EGP 308.3bn allocated to Egypt economic authorities to support services, development projects    Chief of Egypt's Financial Regulator elected as committee head at IOSCO    Washington calls for resumption of GERD talks    Egypt, Saudi Arabia aim to restore calm in Palestinian territories    Comedy actress Nadia Al-Iraqia passes away from COVID-19    Egypt's Health Ministry launches awareness campaigns against COVID-19    Sudan pledges to investigate killing of 2 protestors during peaceful sit-in    Egypt scales up readiness of hospitals nationwide for Eid Al-Fitr holidays    Egyptian hospitals in Sinai on alert amid Israeli aggression on Gaza    Egypt announces Thursday 1st day of Eid Al-Fitr    Nuweiba: Egypt's paradise of serenity    Egypt's trade deficit down 1.2% to $3.34bn in February 2021: CAPMAS    Global economic recovery to improve debt service coverage ratios: Moody's    Egypt's current account deficit jumps to $7.6 bln in 1H of FY2020/21: CBE    India signs an agreement to buy 300,000 doses of Remdesivir from Eva Pharma    Egypt will locally manufacture first 2m Sinovac vaccine doses by June-end    Turkey seeks to restore 'historic unity' with Egyptian people: Erdogan    Elneny's Arsenal targets 'remontada' in Europa League semi-finals    Zamalek eye return to victories at expense of Smouha in Egyptian Premier League    Al Ahly face injuries as they take on Al Ittihad Alexandria    Egypt buys 30 Rafale fighter jets from France    Direct flights between Russia and Egypt will resume in June, Ambassador    Egypt's Ahly is establishing a new stadium, expected to be 'sports complex'    Blinken presses Ethiopia's Abiy to ensure full withdrawal of Eritrean troops from Tigray    Forces opposed to Somali president control parts of Mogadishu    Nine people executed in Egypt over Kerdasa police killings in 2013    UEFA investigating Ibrahimovic's alleged ties to betting company    61 doctors died from coronavirus since start of April: Egypt's medical syndicate    Egypt targets 5.6% inflation rate in FY2020/21, 6% in FY2021/22    Egypt allocates EGP 132 bln to modernise railway system: Transport minister    Real Madrid not thinking about any Super League sanctions: Zidane    Total declares force majeure on Mozambique LNG after attacks    All the winners at the 93rd Academy Awards    Egypt's Ahly granted approval to build new stadium on Cairo outskirts    Aswan Int'l Women's Film Festival dedicates 5th edition to Kawthar Heikal    BREAKING: Egypt's information minister Osama Heikal resigns amid parliamentary criticism    'War was not Egypt's aim, but peace was the ultimate goal,' Sisi says on Sinai Liberation Day anniversary    Factbox: Key nominations for the 2021 Academy Awards    Old Cairo's Al-Fustat will be revamped on Egyptian President's directives    Veteran Egyptian journalist Makram Mohamed Ahmed passes away at 86    Allianz Egypt partners with IGNITE to equip brand ambassadors for 2021 Olympics    Hassan Allam consortium wins contract to manage, operate Grand Egyptian Museum    Seasoned Egyptian screenwriter Wahid Hamed dies at 76    







Thank you for reporting!
This image will be automatically disabled when it gets reported by several people.





UAE launches COVID-19 vaccine production with China's Sinopharm
Published in Ahram Online on 29 - 03 - 2021

A new factory in Abu Dhabi will start manufacturing a COVID-19 vaccine from Chinese pharmaceutical giant Sinopharm later this year under a joint venture between Sinopharm and Abu Dhabi-based technology company Group 42 (G42).
While the new plant scales up, interim production of the vaccine has already begun in the emirate of Ras al-Khaimah by Gulf Pharmaceutical Industries PSC (Julphar).
The venture is an expansion of Chinese diplomacy in the Gulf region and helps the United Arab Emirates' quest to diversify its economy away from hydrocarbon production.
The new plant, which is being built in the Khalifa Industrial Zone of Abu Dhabi (KIZAD), will have a production capacity of 200 million doses a year with three filling lines and five automated packaging lines, a statement from the joint venture said on Monday.
The vaccine will be called Hayat-Vax when manufactured in the UAE, but is the same inactivated vaccine from the Beijing Institute of Biological Product (BiBP), a unit of Sinopharm's China National Biotec Group (CNBG), that the UAE approved for general use in December.
"Hayat-Vax is the first COVID-19 vaccine to be produced in the Arab world," the JV said.
As part of the joint venture, interim production of Hayat-Vax has begun in Ras al-Khaimah, one of the UAE's seven emirates, under a deal between G42 and Julphar, the statement said.
That interim production line has an initial capacity of 2 million doses per month and no details were given about how long production will continue there.
Julphar's share price surged 14.4% to 1.4 dirhams ($0.3812), its biggest single-day gain since June.
The UAE, through G42, hosted Phase III clinical trials of the Sinopharm vaccine from July, which later expanded to other countries in the region including Bahrain. The UAE approved the vaccine for frontline workers in September before making it available to the general public in December.
G42 has previously said it has distribution and manufacturing agreements with Sinopharm and hopes to provide the UAE and other states in the region with the vaccine.
The deal was launched during a two-day visit to the UAE by Chinese Foreign Minister Wang Yi which ended on Sunday.
The joint venture also includes a purpose-built research and development hub for life sciences, biotechnology and vaccine production in KIZAD.
"Our joint venture is also actively looking to bring our capabilities to new markets around the world," G42 CEO Peng Xiao said.
The UAE has said its trials showed the vaccine has 86% efficacy, while Sinopharm reports 79.34% efficacy based on interim results.
Some people in the UAE failed to develop sufficient antibodies after a second dose of the Sinopharm vaccine and were given a third dose, the UAE health ministry said this month. It said the number was "minimal" compared to the number of vaccines administered.
On Sunday, a Sinopharm executive said the company will need to assess results from overseas Phase III clinical trials to decide whether its two-shot vaccine should be followed by a booster shot.
"Thanks to the close collaboration with the UAE, Sinopharm's vaccine has been now administered to millions of people in the country, the region, and the world," Sinopharm Chairman Liu Jingzhen said at a virtual launch also attended by UAE Foreign Affairs Minister Sheikh Abdullah bin Zayed Al Nahyan.


Clic here to read the story from its source.